LISPOMIX Trademark

Trademark Overview

On Friday, September 21, 2018, a trademark application was filed for LISPOMIX with the United States Patent and Trademark Office. The USPTO has given the LISPOMIX trademark a serial number of 88127015. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 15, 2021. This trademark is owned by Wockhardt Bio AG. The LISPOMIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing insulin for the treatment and prevention of diabetes; inhalers filled with insulin
lispomix

General Information

Serial Number88127015
Word MarkLISPOMIX
Filing DateFriday, September 21, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations containing insulin for the treatment and prevention of diabetes; inhalers filled with insulin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWockhardt Bio AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug 6300
CH
Party NameWockhardt Bio AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug 6300
CH

Trademark Events

Event DateEvent Description
Monday, November 15, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 28, 2021EXTENSION 4 GRANTED
Sunday, March 28, 2021EXTENSION 4 FILED
Sunday, March 28, 2021TEAS EXTENSION RECEIVED
Friday, October 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 7, 2020EXTENSION 3 GRANTED
Wednesday, October 7, 2020EXTENSION 3 FILED
Wednesday, October 7, 2020TEAS EXTENSION RECEIVED
Tuesday, March 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 20, 2020EXTENSION 2 GRANTED
Friday, March 20, 2020EXTENSION 2 FILED
Friday, March 20, 2020TEAS EXTENSION RECEIVED
Thursday, October 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2019EXTENSION 1 GRANTED
Tuesday, October 1, 2019EXTENSION 1 FILED
Tuesday, October 1, 2019TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 3, 2019ASSIGNED TO EXAMINER
Friday, September 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 25, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

lispomix insulin diabetes inhalers filled prevention treatment preparations containing pharmaceutical